Oral versus intravenous fluoropyrimidines for metastatic colorectal cancer.
Editorial Group: Cochrane Colorectal Cancer Group
Published Online: 23 OCT 2000
Copyright © 2008 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Strickland A, Harper P, Karapetis C, Steer CB, Yip D. Oral versus intravenous fluoropyrimidines for metastatic colorectal cancer. (Protocol). Cochrane Database of Systematic Reviews 2000, Issue 4. Art. No.: CD002889. DOI: 10.1002/14651858.CD002889.
- Publication Status: Edited (no change to conclusions)
- Published Online: 23 OCT 2000
This is the protocol for a review and there is no abstract. The objectives are as follows:
Our primary objective is to conduct a systematic review of the randomised trials comparing intravenous 5-fluorouracil with any oral fluoropyrimidine to assess the effect of chemotherapy on overall survival in patients with colo-rectal cancer. Our secondary objective will be to assess the relative response rates, toxicities and effects on quality of life of these two treatments.